Abiomed, Inc. (ABMD) Post Q1 GAAP Loss of $0.04/Share; Reaffirms Rev Outlook
Tweet
Share
E-mailGet Alerts ABMD Hot Sheet
Price: $381.02 --0%
Financial Fact:
Loss from operations: 14.51M
Today's EPS Names:
VAXX, EGRX, AFIB, More
Financial Fact:
Loss from operations: 14.51M
Today's EPS Names:
VAXX, EGRX, AFIB, More
Join SI Premium – FREE
Abiomed, Inc. (NASDAQ: ABMD) reported Q1 GAAP EPS of ($0.04), which may note compare to the analyst estimate of $0.06. Revenue for the quarter came in at $42.7 million versus the consensus estimate of $42.93 million.
Abiomed, Inc. sees FY2013 revenue of $180-185 million, versus the consensus of $183.8 million.
For earnings history and earnings-related data on Abiomed, Inc. (ABMD) click here.
Abiomed, Inc. sees FY2013 revenue of $180-185 million, versus the consensus of $183.8 million.
For earnings history and earnings-related data on Abiomed, Inc. (ABMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Burry doubles down on Nebius short after stock surges 34% on earnings
- Rekor Systems, Inc. (REKR) Tops Q2 EPS by 3c
- MeiraGTx Holdings plc (MGTX) Tops Q2 EPS by 202c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
